|
Dinah Misner1; Kusum Gupta1; Xuan Luong1; Jerome Deval1; Kha Le2; Doug Clark1; David McGowan3; Meenakshi Venkatraman1; Matthew McClure1; David B. Smith2; Tse-I Lin1; Julian Symons2; Lawrence M. Blatt2; Leonid N. Beigelman2; Sushmita Chanda2; 1Aligos Therapeutics, Inc.; 2Aligos Therapeutics, Inc., South San Francisco, CA, USA; 3Aligos Belgium BV
|